Ariel Marciscano, MD, is a board-certified radiation oncologist and physician-scientist with a subspecialty focus in central nervous system radiation oncology. He serves as a radiation oncologist at Massachusetts General Hospital. Clinically, his focus includes central nervous system radiation oncology, stereotactic radiosurgery and stereotactic radiotherapy, and proton beam therapy. His research centers on the interface of radiation and immunotherapy, with an emphasis on synergistic combination strategies. He studies immune responses within the tumor microenvironment following stereotactic radiation and develops radiosensitization and treatment-optimization approaches in central nervous system oncology. Marciscano has been recognized with honors including a Stand Up To Cancer Catalyst Award as a Young Investigator/Team Member and an RSNA R&E Foundation Research Fellow Grant, along with accolades from ASTRO and AACR. He previously held faculty roles at Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, where he directed the Radiation Therapy Preclinical Core. He earned his medical degree from the New York University School of Medicine, completed residency in radiation oncology at The Johns Hopkins Hospital, and pursued a fellowship in Immunotherapy at the National Cancer Institute.
Attending Physician
Medical School
2011
Residency
Fellowship